Suvizumab
| Monoclonal antibody | |
|---|---|
| Type | Whole antibody |
| Source | Humanized |
| Target | HIV-1 |
| Clinical data | |
| Identifiers | |
1116433-11-4  | |
| None | |
| Chemical data | |
| (what is this?) (verify) | |
Suvizumab is an antiviral and immunomodulator. It binds to HIV-1.[1]
References
- ↑ World Health Organization (2010). "International Nonproprietary Names for Pharmaceutical Substances (INN). Proposed INN: List 103" (PDF). WHO Drug Information.
| ||||||||||||||||||||||||||||||||||||||||||||||||||